Related Experiment Video
Updated: May 30, 2026
06:58
Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs
Published on: May 18, 2022
MicroRNA-restricted transgene expression in the retina
Marianthi Karali1, Anna Manfredi, Agostina Puppo
1Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
Plos One
|August 6, 2011
Summary
MicroRNAs can control gene expression from adeno-associated viral (AAV) vectors in the retina. This research shows specific microRNAs restrict AAV transgene expression to targeted retinal cells, crucial for treating inherited blindness.
Area of Science:
- Ophthalmology
- Molecular Biology
- Gene Therapy
Background:
- Adeno-associated viral (AAV) vectors are used for retinal gene therapy.
- MicroRNAs offer potential for fine-tuning transgene expression.
- Targeting specific retinal cells is key for treating inherited retinal dystrophies.
Purpose of the Study:
- To evaluate retinal microRNAs for restricting AAV transgene expression.
- To target specific retinal cell types for inherited blinding conditions.
Main Methods:
- Generated AAV2/5 vectors with miR-124 or miR-204 complementary sequences.
- Administered vectors subretinally to mice and pigs.
- Analyzed EGFP expression to assess transgene restriction.
Main Results:
- miR-124 and miR-204 sequences efficiently restricted AAV transgene expression.
- Restriction was observed in retinal pigment epithelium and photoreceptors.
- Effective transgene restriction occurred at therapeutically relevant low vector doses.
Conclusions:
- MicroRNA-mediated regulation can restrict AAV expression to specific retinal cells.
- This approach enhances gene expression control using ubiquitous or cell-specific promoters.
- Enables precise gene targeting for inherited retinal diseases.
